Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:3157-3163

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ausma, J.
Right arrow Articles by Borgers, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ausma, J.
Right arrow Articles by Borgers, M.

(Circulation. 1997;96:3157-3163.)
© 1997 American Heart Association, Inc.


Articles

Structural Changes of Atrial Myocardium due to Sustained Atrial Fibrillation in the Goat

Jannie Ausma, PhD; Maurits Wijffels, MD, PhD; Fred Thoné; Luc Wouters, MSc; Maurits Allessie, MD, PhD; ; Marcel Borgers, PhD

From the Department of Molecular Cell Biology and Genetics (J.A., M.B.) and Department of Physiology (M.W., M.A.), Cardiovascular Research Institute Maastricht, Maastricht University, Netherlands, and Janssen Research Foundation (F.T., L.W., M.B.), Beerse, Belgium.

Correspondence to Prof Dr M. Borgers, Department of Molecular Cell Biology and Genetics, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. E-mail secrmcb{at}molcelb.unimaas.nl

Background After cardioversion of sustained atrial fibrillation (AF), the electrical and contractile functions of the atria are impaired, and recurrences of AF frequently occur. Whether remodeling of the structure of atrial myocardium is the basis for this problem is not known.

Methods and Results Sustained AF was induced by electrical pacing in 13 goats instrumented long-term. The goats were killed after 9 to 23 weeks, and the atrial myocardium was examined by light and electron microscopy. The changes were quantified in left and right atrial free walls, appendages, trabeculae, the interatrial septum, and the bundle of Bachmann. A substantial proportion of the atrial myocytes (up to 92%) revealed marked changes in their cellular substructures, such as loss of myofibrils, accumulation of glycogen, changes in mitochondrial shape and size, fragmentation of sarcoplasmic reticulum, and dispersion of nuclear chromatin. These changes were accompanied by an increase in size of the myocytes (up to 195%). There were virtually no signs of cellular degeneration, and the interstitial space remained unaltered. The duration of sustained AF did not significantly affect the degree of myolytic cell changes.

Conclusions Sustained AF in goats leads to predominantly structural changes in the atrial myocytes similar to those seen in ventricular myocytes from chronic hibernating myocardium. These structural changes may explain the depressed contractile function of atrial myocardium after cardioversion. This goat model of AF offers a new approach to study the cascade of events leading to sustained AF and its maintenance.


Key Words: atrium • fibrillation • myocytes • structure • stunning, myocardial




This article has been cited by other articles:


Home page
EuropaceHome page
S. K. Kim, H.-N. Pak, J. H. Park, K. J. Ko, J. S. Lee, J. I. Choi, D. H. Choi, and Y.-H. Kim
Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion
Europace, December 1, 2009; 11(12): 1632 - 1638.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. Nishida, G. Michael, D. Dobrev, and S. Nattel
Animal models for atrial fibrillation: clinical insights and scientific opportunities
Europace, October 29, 2009; (2009) eup328v1.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bukowska, U. Lendeckel, A. Krohn, G. Keilhoff, S. t. Have, K. H. Neumann, and A. Goette
Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney
Europace, October 1, 2008; 10(10): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. John, M. K. Stiles, P. Kuklik, S. T. Chandy, G. D. Young, L. Mackenzie, L. Szumowski, G. Joseph, J. Jose, S. G. Worthley, et al.
Electrical remodelling of the left and right atria due to rheumatic mitral stenosis
Eur. Heart J., September 2, 2008; 29(18): 2234 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
J. L. Serra and M. Bendersky
Review: Atrial fibrillation and renin-angiotensin system
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 215 - 223.
[Abstract] [PDF]


Home page
Eur Heart JHome page
C. Schneider, R. Malisius, K. Krause, F. Lampe, E. Bahlmann, S. Boczor, M. Antz, S. Ernst, and K.-H. Kuck
Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation
Eur. Heart J., June 1, 2008; 29(11): 1397 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, L. Ke, A.-J. Dijkhuis, X. Qi, A. Shiroshita-Takeshita, S. Nattel, R. H. Henning, and H. H. Kampinga
Heat shock proteins as molecular targets for intervention in atrial fibrillation
Cardiovasc Res, June 1, 2008; 78(3): 422 - 428.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. I. Skalidis, M. I. Hamilos, I. K. Karalis, G. Chlouverakis, G. E. Kochiadakis, and P. E. Vardas
Isolated Atrial Microvascular Dysfunction in Patients With Lone Recurrent Atrial Fibrillation
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2053 - 2057.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Dinanian, C. Boixel, C. Juin, J.-S. Hulot, A. Coulombe, C. Rucker-Martin, N. Bonnet, B. Le Grand, M. Slama, J.-J. Mercadier, et al.
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation
Eur. Heart J., May 1, 2008; 29(9): 1190 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Bukowska, L. Schild, G. Keilhoff, D. Hirte, M. Neumann, A. Gardemann, K. H. Neumann, F.-W. Rohl, C. Huth, A. Goette, et al.
Mitochondrial Dysfunction and Redox Signaling in Atrial Tachyarrhythmia
Experimental Biology and Medicine, May 1, 2008; 233(5): 558 - 574.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. C. Roberts-Thomson, I. H. Stevenson, P. M. Kistler, H. M. Haqqani, J. C. Goldblatt, P. Sanders, and J. M. Kalman
Anatomically Determined Functional Conduction Delay in the Posterior Left Atrium: Relationship to Structural Heart Disease
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Goette, A. Bukowska, U. Lendeckel, M. Erxleben, M. Hammwohner, D. Strugala, J. Pfeiffenberger, F.-W. Rohl, C. Huth, M. P.A. Ebert, et al.
Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
Circulation, February 12, 2008; 117(6): 732 - 742.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mayr, S. Yusuf, G. Weir, Y.-L. Chung, U. Mayr, X. Yin, C. Ladroue, B. Madhu, N. Roberts, A. De Souza, et al.
Combined metabolomic and proteomic analysis of human atrial fibrillation.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al.
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
Europace, January 1, 2008; 10(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Burstein, X.-Y. Qi, Y.-H. Yeh, A. Calderone, and S. Nattel
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling
Cardiovasc Res, December 1, 2007; 76(3): 442 - 452.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA)
Eur. Heart J., November 2, 2007; 28(22): 2803 - 2817.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al.
Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Europace, November 1, 2007; 9(11): 1006 - 1023.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bollmann, D. Husser, M. Stridh, F. Holmqvist, A. Roijer, C. J. Meurling, L. Sornmo, and S. B. Olsson
Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation
Europace, August 1, 2007; 9(8): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Petrutiu, A. V. Sahakian, and S. Swiryn
Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans
Europace, July 1, 2007; 9(7): 466 - 470.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. C. Van Gelder and M. E.W. Hemels
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
Europace, November 1, 2006; 8(11): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. L. Ngaage, H. V. Schaff, S. A. Barnes, T. M. Sundt III, C. J. Mullany, J. A. Dearani, R. C. Daly, and T. A. Orszulak
Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?
Ann. Thorac. Surg., October 1, 2006; 82(4): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. de Haan, M. Greiser, E. Harks, Y. Blaauw, A. van Hunnik, S. Verheule, M. Allessie, and U. Schotten
AVE0118, Blocker of the Transient Outward Current (Ito) and Ultrarapid Delayed Rectifier Current (IKur), Fully Restores Atrial Contractility After Cardioversion of Atrial Fibrillation in the Goat
Circulation, September 19, 2006; 114(12): 1234 - 1242.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
Eur Heart JHome page
N. Dagres, G. Karatasakis, F. Panou, G. Athanassopoulos, T. Maounis, E. Tsougos, K. Kourea, I. Malakos, D. Th. Kremastinos, and D. V. Cokkinos
Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation
Eur. Heart J., September 1, 2006; 27(17): 2062 - 2068.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Yin, D. Dalal, Z. Liu, J. Wu, D. Liu, X. Lan, Y. Dai, L. Su, Z. Ling, Q. She, et al.
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
Eur. Heart J., August 1, 2006; 27(15): 1841 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. A. Dezsi, A. Szucs, G. Szucs, A. Roka, O. Kiss, D. Becker, and B. Merkely
Short-term effect of rate control on plasma endothelin levels of patients with tachyarrhythmias.
Experimental Biology and Medicine, June 1, 2006; 231(6): 852 - 856.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Osranek and J. B. Seward
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up: reply
Eur. Heart J., March 2, 2006; 27(6): 756 - 756.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. T. Ellinor, A. F. Low, and C. A. MacRae
Reduced apelin levels in lone atrial fibrillation
Eur. Heart J., January 2, 2006; 27(2): 222 - 226.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Osranek, F. Bursi, K. R. Bailey, B. R. Grossardt, R. D. Brown Jr, S. L. Kopecky, T. S. Tsang, and J. B. Seward
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up
Eur. Heart J., December 1, 2005; 26(23): 2556 - 2561.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Reant, S. Lafitte, P. Jais, K. Serri, R. Weerasooriya, M. Hocini, X. Pillois, J. Clementy, M. Haissaguerre, and R. Roudaut
Reverse Remodeling of the Left Cardiac Chambers After Catheter Ablation After 1 Year in a Series of Patients With Isolated Atrial Fibrillation
Circulation, November 8, 2005; 112(19): 2896 - 2903.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. V. Naccarelli
Antiadrenergic Therapy in the Control of Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S33 - S43.
[Abstract] [PDF]


Home page
CirculationHome page
G. Di Salvo, P. Caso, R. Lo Piccolo, A. Fusco, A. R. Martiniello, M. G. Russo, A. D'Onofrio, S. Severino, P. Calabro, G. Pacileo, et al.
Atrial Myocardial Deformation Properties Predict Maintenance of Sinus Rhythm After External Cardioversion of Recent-Onset Lone Atrial Fibrillation: A Color Doppler Myocardial Imaging and Transthoracic and Transesophageal Echocardiographic Study
Circulation, July 19, 2005; 112(3): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Khan
Identifying and understanding the role of pulmonary vein activity in atrial fibrillation
Cardiovasc Res, December 1, 2004; 64(3): 387 - 394.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Deroubaix, T. Folliguet, C. Rucker-Martin, S. Dinanian, C. Boixel, P. Validire, P. Daniel, A. Capderou, and S. N. Hatem
Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1918 - 1926.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G. D. Veenhuyzen, C. S. Simpson, and H. Abdollah
Atrial fibrillation
Can. Med. Assoc. J., September 28, 2004; 171(7): 755 - 760.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, P. M. Kistler, J. B. Morton, S. J. Spence, and J. M. Kalman
Remodeling of Sinus Node Function in Patients With Congestive Heart Failure: Reduction in Sinus Node Reserve
Circulation, August 24, 2004; 110(8): 897 - 903.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. L.J.L. Thijssen, J. Ausma, L. Gorza, H. M.W. van der Velden, M. A. Allessie, I. C. Van Gelder, M. Borgers, and G. J.J.M. van Eys
Troponin I Isoform Expression in Human and Experimental Atrial Fibrillation
Circulation, August 17, 2004; 110(7): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Verheule, E. Wilson, S. Banthia, T. H. Everett IV, S. Shanbhag, H. J. Sih, and J. Olgin
Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H634 - H644.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Kistler, P. Sanders, S. P. Fynn, I. H. Stevenson, S. J. Spence, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrophysiologic and electroanatomic changes in the human atrium associated with age
J. Am. Coll. Cardiol., July 7, 2004; 44(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O Leone, G Boriani, B Chiappini, D Pacini, G Cenacchi, S Martin Suarez, C Rapezzi, M.L Bacchi Reggiani, and G Marinelli
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation
Eur. Heart J., July 2, 2004; 25(14): 1237 - 1241.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Verheule, T. Sato, T. Everett IV, S. K. Engle, D. Otten, M. Rubart-von der Lohe, H. O. Nakajima, H. Nakajima, L. J. Field, and J. E. Olgin
Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-{beta}1
Circ. Res., June 11, 2004; 94(11): 1458 - 1465.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Khargi, B. Lemke, H. Haardt, K.-M. Muller, A. Mugge, A. Laczkovics, and T. Deneke
Concomitant anti-arrhythmic surgery, using irrigated cooled-tip radiofrequency ablation, to treat permanent atrial fibrillation in CABG patients: expansion of the indication?
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Costoli, A. Bartolomucci, G. Graiani, D. Stilli, G. Laviola, and A. Sgoifo
Effects of chronic psychosocial stress on cardiac autonomic responsiveness and myocardial structure in mice
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2133 - H2140.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, H. H Kampinga, and R. H Henning
Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation
Cardiovasc Res, June 1, 2004; 62(3): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C-J A Lindholm, O Fredholm, S-J Moller, N Edvardsson, T Kronvall, T Pettersson, V Firsovaite, A Roijer, C J Meurling, P G Platonov, et al.
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil
Heart, May 1, 2004; 90(5): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, J. B. Morton, P. M. Kistler, S. J. Spence, N. C. Davidson, A. Hussin, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrophysiological and Electroanatomic Characterization of the Atria in Sinus Node Disease: Evidence of Diffuse Atrial Remodeling
Circulation, March 30, 2004; 109(12): 1514 - 1522.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt
Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation
Circulation, March 23, 2004; 109(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. M. Porthan, J. H. Melin, J. T. Kupila, K. K. K. Venho, and M. M. Partinen
Prevalence of Sleep Apnea Syndrome in Lone Atrial Fibrillation: A Case-Control Study
Chest, March 1, 2004; 125(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Bauer, A. D. McDonald, and J.K. Donahue
Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure
Cardiovasc Res, March 1, 2004; 61(4): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Khan, G. W. Moe, N. Nili, E. Rezaei, M. Eskandarian, J. Butany, and B. H. Strauss
The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 68 - 76.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Marin, V. Roldan, V. Climent, and G. Y. H. Lip
Matrix metalloproteinases in atrial fibrillation
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 152 - 152.
[Full Text] [PDF]


Home page
EuropaceHome page
M. P. van den Berg, I. C. van Gelder, and D. J. van Veldhuisen
Depletion of atrial natriuretic peptide during longstanding atrial fibrillation
Europace, January 1, 2004; 6(5): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, A. C. Skanes, G. Guiraudon, C. Guiraudon, A. D. Krahn, R. Yee, and G. J. Klein
Role of the Posterior Left Atrium and Pulmonary Veins in Human Lone Atrial Fibrillation: Electrophysiological and Pathological Data From Patients Undergoing Atrial Fibrillation Surgery
Circulation, December 23, 2003; 108(25): 3108 - 3114.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al.
Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results
Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, J. B. Morton, P. M. Kistler, J. K. Vohra, J. M. Kalman, and P. B. Sparks
Reversal of Atrial Mechanical Dysfunction After Cardioversion of Atrial Fibrillation: Implications for the Mechanisms of Tachycardia-Mediated Atrial Cardiomyopathy
Circulation, October 21, 2003; 108(16): 1976 - 1984.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Sanders, J. B. Morton, N. C. Davidson, S. J. Spence, J. K. Vohra, P. B. Sparks, and J. M. Kalman
Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in Humans
Circulation, September 23, 2003; 108(12): 1461 - 1468.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Boixel, V. Fontaine, C. Rucker-Martin, P. Milliez, L. Louedec, J.-B. Michel, M.-P. Jacob, and S. N. Hatem
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 336 - 344.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, K. Arakawa, and K. Saku
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2197 - 2204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rosa, J.-P. Maury, J. Terrand, X. Lyon, P. Kucera, L. Kappenberger, and E. Raddatz
Ectopic pacing at physiological rate improves postanoxic recovery of the developing heart
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2384 - H2392.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation
Circulation, May 27, 2003; 107(20): 2615 - 2622.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. Marin, V. Roldan, V. Climent, A. Garcia, P. Marco, and G. Y.H. Lip
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?
Stroke, May 1, 2003; 34(5): 1181 - 1186.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Ausma, H. M.W. van der Velden, M.-H. Lenders, E. P. van Ankeren, H. J. Jongsma, F. C.S. Ramaekers, M. Borgers, and M. A. Allessie
Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat
Circulation, April 22, 2003; 107(15): 2051 - 2058.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo
Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation
Circulation, April 8, 2003; 107(13): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Nattel
Atrial Electrophysiology and Mechanisms of Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1_suppl): S5 - S11.
[Abstract] [PDF]


Home page
ChestHome page
L.-P. Lai, C.-C. Tsai, M.-J. Su, J.-L. Lin, Y.-S. Chen, Y.-Z. Tseng, and S. K. S. Huang
Atrial Fibrillation Is Associated With Accumulation of Aging-Related Common Type Mitochondrial DNA Deletion Mutation in Human Atrial Tissue
Chest, February 1, 2003; 123(2): 539 - 544.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Dimmer, T. Szili-Torok, R. Tavernier, T. Verstraten, and L. J. Jordaens
Initiating mechanisms of paroxysmal atrial fibrillation
Europace, January 1, 2003; 5(1): 1 - 9.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. A. Thomas, J. A. Fallavollita, G. Suzuki, M. Borgers, and J. M. Canty Jr
Dissociation of Regional Adaptations to Ischemia and Global Myolysis in an Accelerated Swine Model of Chronic Hibernating Myocardium
Circ. Res., November 15, 2002; 91(10): 970 - 977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Narayan, F. Bode, P. L. Karasik, and M. R. Franz
Alternans of Atrial Action Potentials During Atrial Flutter as a Precursor to Atrial Fibrillation
Circulation, October 8, 2002; 106(15): 1968 - 1973.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. E. Schafler, K. Kirmanoglou, P. Pecher, A. Hannekum, and B. Schumacher
Overexpression of heat shock protein 60/10 in myocardium of patients with chronic atrial fibrillation
Ann. Thorac. Surg., September 1, 2002; 74(3): 767 - 770.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ohara, Z. Qu, M.-H. Lee, K. Ohara, C. Omichi, W. J. Mandel, P.-S. Chen, and H. S. Karagueuzian
Increased vulnerability to inducible atrial fibrillation caused by partial cellular uncoupling with heptanol
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1116 - H1122.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Verheule, E. E Wilson, R. Arora, S. K Engle, L. R Scott, and J. E Olgin
Tissue structure and connexin expression of canine pulmonary veins
Cardiovasc Res, September 1, 2002; 55(4): 727 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Calpains and cytokines in fibrillating human atria
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H264 - H272.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Ausma and M. Borgers
Dedifferentiation of atrial cardiomyocytes: from in vivo to in vitro
Cardiovasc Res, July 1, 2002; 55(1): 9 - 12.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Rucker-Martin, F. Pecker, D. Godreau, and S. N Hatem
Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro
Cardiovasc Res, July 1, 2002; 55(1): 38 - 52.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. P. van den Berg, G. Tjeerdsma, P. J. de Kam, F. Boomsma, H. J.G.M. Crijns, and D. J. van Veldhuisen
Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure
Eur J Heart Fail, June 1, 2002; 4(3): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Jalife, O. Berenfeld, and M. Mansour
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 204 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Allessie, J. Ausma, and U. Schotten
Electrical, contractile and structural remodeling during atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 230 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Goette, U. Lendeckel, and H. U Klein
Signal transduction systems and atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M.W van der Velden and H. J Jongsma
Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets
Cardiovasc Res, May 1, 2002; 54(2): 270 - 279.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
Cardiovasc Res, May 1, 2002; 54(2): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kostin, G. Klein, Z. Szalay, S. Hein, E. P Bauer, and J. Schaper
Structural correlate of atrial fibrillation in human patients
Cardiovasc Res, May 1, 2002; 54(2): 361 - 379.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, J. Ausma, I. C van Gelder, J. J.L Van Der Want, W. H van Gilst, H. J.G.M Crijns, and R. H Henning
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Kneller, H. Sun, N. Leblanc, and S. Nattel
Remodeling of Ca2+-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation
Cardiovasc Res, May 1, 2002; 54(2): 416 - 426.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. L.J.L Thijssen, H. M.W van der Velden, E. P van Ankeren, J. Ausma, M. A Allessie, M. Borgers, G. J.J.M van Eys, and H. J Jongsma
Analysis of altered gene expression during sustained atrial fibrillation in the goat
Cardiovasc Res, May 1, 2002; 54(2): 427 - 437.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Shinagawa, H. Mitamura, S. Ogawa, and S. Nattel
Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling
Cardiovasc Res, May 1, 2002; 54(2): 438 - 446.
[Abstract] [Full Text] [PDF]